NanoVibronix 

$4.02
102
-$0.29-6.73% Thursday 21:00
+$0.03+0.75%Friday 00:07Pre-market

Statistics

Day High
4.25
Day Low
4.01
52W High
162.5
52W Low
2.09
Volume
32,684
Avg. Volume
79,888
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25FebExpected
Q4 0
Q3 2020
Q4 2025
-220
-219.67
-219.33
-219
Expected EPS
N/A
Actual EPS
N/A

Financials

-107.57%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.11MRevenue
-2.27MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation competes with NanoVibronix in the medical devices sector, focusing on products for various conditions that can overlap with NanoVibronix's pain management and wound healing solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers a wide range of medical devices that compete directly with NanoVibronix's offerings, especially in the areas of pain management and therapeutic ultrasound technologies.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes in the same space as NanoVibronix, offering products that can be used in wound care, surgery, and pain management.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is a competitor due to its development and marketing of medical devices, including surgical equipment and orthopaedic devices that can be used in applications similar to NanoVibronix's.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes with NanoVibronix in the orthopaedic market, particularly in products related to bone healing, which may overlap with NanoVibronix's therapeutic ultrasound technology.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers medical devices across various segments, including cardiovascular and neuromodulation, competing with NanoVibronix's pain management solutions.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. competes by offering robotic-assisted surgical systems, which can be used in minimally invasive surgeries, a field where NanoVibronix's pain management and healing solutions could be applied.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences Corporation is a competitor in the field of patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, areas where NanoVibronix's technologies could be beneficial.

About

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Show more...
CEO
Mr. Stephen R. Brown CPA
Employees
31
Country
United States
ISIN
US63008J7028

Listings

0 Comments

Share your thoughts

FAQ

What is NanoVibronix stock price today?
The current price of NAOV is $4.02 USD — it has decreased by -6.73% in the past 24 hours. Watch NanoVibronix stock price performance more closely on the chart.
What is NanoVibronix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange NanoVibronix stocks are traded under the ticker NAOV.
Is NanoVibronix stock price growing?
NAOV stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year NanoVibronix has showed a -22.84% decrease.
What is NanoVibronix revenue for the last year?
NanoVibronix revenue for the last year amounts to 2.11M USD.
What is NanoVibronix net income for the last year?
NAOV net income for the last year is -2.27M USD.
How many employees does NanoVibronix have?
As of September 04, 2026, the company has 31 employees.
In which sector is NanoVibronix located?
NanoVibronix operates in the Health & Wellness sector.
When did NanoVibronix complete a stock split?
The last stock split for NanoVibronix was on August 12, 2025 with a ratio of 1:10.
Where is NanoVibronix headquartered?
NanoVibronix is headquartered in Tyler, United States.